Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rozerem for GERD symptoms in chronic insomnia
NCT01128582Phase 3Unknown
- Sponsor
- Southern Arizona VA Health Care System
- Start
- Mar 2009
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ramelteon in gastroesophageal reflux disease (GERD), sponsored by Southern Arizona VA Health Care System. Status: unknown.
02
Drugs
ramelteon
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT01128582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01128582.